Related Experiment Videos
Why do so many people drop out from auto-injection therapy for impotence?
S E Althof1, L A Turner, S B Levine
1Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Journal of Sex & Marital Therapy
|January 1, 1989
Summary
Patient acceptance of intracavernous injection therapy for impotence is low, with a 46% dropout rate. Key reasons for declining or stopping treatment include fear of self-injection and perceived lack of efficacy.
Area of Science:
- Urology
- Andrology
- Sexual Medicine
Background:
- Intracavernous injection of vasoactive substances is an effective treatment for erectile dysfunction (impotence).
- Limited data exists on patient acceptance and long-term utilization of this therapy.
Purpose of the Study:
- To prospectively evaluate patient utilization rates of intracavernous injection therapy.
- To identify reasons for patient decline or discontinuation of self-injection therapy for impotence.
Main Methods:
- Prospective study following patients and partners over a 2-year period.
- Documentation of patient utilization, reasons for declining, and reasons for discontinuing therapy.
Main Results:
- A cumulative dropout rate of 46% was observed.
- Patients were most likely to leave the program post-evaluation or during the trial dose phase.
- Primary reasons for declining treatment included psychological barriers to self-injection and concerns about side effects.
- Perceived lack of efficacy was the main reason for treatment discontinuation.
Conclusions:
- Significant patient and programmatic obstacles hinder the utilization of self-injection therapy for erectile dysfunction.
- Addressing patient acceptance, psychological concerns, and perceived efficacy is crucial for improving treatment adherence.